- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Valsalva Maneuver gets modified for the treatment of SVT
The first activity in the management of AV nodal—dependent supraventricular tachycardia is to try Valsalva Maneuver and there by blocking AV nodal conduction temporarily.
However, the success of the Valsalva Maneuver can be confounded by hypotension and sympathetic activation often present during supraventricular tachycardia. Thus, while the Valsalva maneuver can be a safe, fast, and easy way to stop supraventricular tachycardia, it is oftentimes ineffective.
In a controlled, prospective clinical trial performed in the emergency department, 428 participants with supraventricular tachycardia were randomized to a standard semi-recumbent Valsalva maneuver vs a semi-recumbent Valsalva maneuver with passive leg raise immediately after the maneuver.
Only 17% of the participants in the standard Valsalva maneuver group achieved a return to sinus rhythm, whereas 43% in the modified Valsalva group did, representing a highly significant difference, with an adjusted odds ratio of 3.7 in favor of the novel Valsalva approach.
This simple adjunct to the Valsalva maneuver has become a “GAME CHANGER” regarding the acute management of supraventricular tachycardias.
This approach can be used safely and more effectively in the emergency department to stop episodic supraventricular tachycardia without the need for adenosine or other interventions, but it may be useful even outside the hospital setting.
You can see a the Modified Valsalva Maneuvre on the following video
[embed]https://www.youtube.com/watch?v=8DIRiOA_OsA[/embed]
You can read the full article about this modified Valsalva Maneuver at Lancet by clicking on the following link
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961485-4/fulltext
However, the success of the Valsalva Maneuver can be confounded by hypotension and sympathetic activation often present during supraventricular tachycardia. Thus, while the Valsalva maneuver can be a safe, fast, and easy way to stop supraventricular tachycardia, it is oftentimes ineffective.
In a controlled, prospective clinical trial performed in the emergency department, 428 participants with supraventricular tachycardia were randomized to a standard semi-recumbent Valsalva maneuver vs a semi-recumbent Valsalva maneuver with passive leg raise immediately after the maneuver.
Only 17% of the participants in the standard Valsalva maneuver group achieved a return to sinus rhythm, whereas 43% in the modified Valsalva group did, representing a highly significant difference, with an adjusted odds ratio of 3.7 in favor of the novel Valsalva approach.
This simple adjunct to the Valsalva maneuver has become a “GAME CHANGER” regarding the acute management of supraventricular tachycardias.
This approach can be used safely and more effectively in the emergency department to stop episodic supraventricular tachycardia without the need for adenosine or other interventions, but it may be useful even outside the hospital setting.
You can see a the Modified Valsalva Maneuvre on the following video
[embed]https://www.youtube.com/watch?v=8DIRiOA_OsA[/embed]
You can read the full article about this modified Valsalva Maneuver at Lancet by clicking on the following link
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961485-4/fulltext
Dr. Manav Aggarwal is a Interventional Cardiologist,Cardiologist and General Physician in Darya Ganj, Delhi and has an experience of more than 10 years in these fields. Dr. Manav Aggarwal practices at Sanjeevan Hospital in Darya Ganj, Delhi.
Next Story